- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-3-3-mer
- Ligands
- 21 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.2: 4 residues within 4Å:- Chain C: Q.263, N.265, S.303, R.412
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Q.263
NAG-NAG-BMA-MAN.12: 4 residues within 4Å:- Chain C: N.246
- Chain G: Y.111
- Chain H: G.29, S.51
1 PLIP interactions:1 interactions with chain H- Hydrogen bonds: H:S.51
NAG-NAG-BMA-MAN.16: 4 residues within 4Å:- Chain K: Q.263, N.265, S.303, R.412
1 PLIP interactions:1 interactions with chain K- Hydrogen bonds: K:Q.263
NAG-NAG-BMA-MAN.26: 4 residues within 4Å:- Chain K: N.246
- Chain O: Y.111
- Chain P: G.29, S.51
1 PLIP interactions:1 interactions with chain P- Hydrogen bonds: P:S.51
NAG-NAG-BMA-MAN.30: 4 residues within 4Å:- Chain Q: Q.263, N.265, S.303, R.412
1 PLIP interactions:1 interactions with chain Q- Hydrogen bonds: Q:Q.263
NAG-NAG-BMA-MAN.40: 4 residues within 4Å:- Chain Q: N.246
- Chain W: Y.111
- Chain X: G.29, S.51
1 PLIP interactions:1 interactions with chain X- Hydrogen bonds: X:S.51
- 6 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.4: 6 residues within 4Å:- Chain C: D.111, N.355, S.357
- Ligands: NAG-NAG-BMA.3, NAG-NAG-BMA.3, NAG.44
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:D.111
NAG-NAG-BMA-MAN-MAN.11: 6 residues within 4Å:- Chain C: E.181, L.231, N.232, V.414, S.415
- Ligands: NAG-NAG.10
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.18: 6 residues within 4Å:- Chain K: D.111, N.355, S.357
- Ligands: NAG-NAG-BMA.17, NAG-NAG-BMA.17, NAG.47
1 PLIP interactions:1 interactions with chain K- Hydrogen bonds: K:D.111
NAG-NAG-BMA-MAN-MAN.25: 6 residues within 4Å:- Chain K: E.181, L.231, N.232, V.414, S.415
- Ligands: NAG-NAG.24
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.32: 6 residues within 4Å:- Chain Q: D.111, N.355, S.357
- Ligands: NAG-NAG-BMA.31, NAG-NAG-BMA.31, NAG.50
1 PLIP interactions:1 interactions with chain Q- Hydrogen bonds: Q:D.111
NAG-NAG-BMA-MAN-MAN.39: 6 residues within 4Å:- Chain Q: E.181, L.231, N.232, V.414, S.415
- Ligands: NAG-NAG.38
No protein-ligand interaction detected (PLIP)- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.5: 6 residues within 4Å:- Chain C: N.103, I.108, D.110, D.111, M.112, R.113
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:R.113
- Hydrogen bonds: C:D.110
NAG-NAG.8: 2 residues within 4Å:- Chain C: N.271, I.292
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 2 residues within 4Å:- Chain C: N.416
- Ligands: NAG-NAG-BMA-MAN-MAN.11
No protein-ligand interaction detected (PLIP)NAG-NAG.19: 6 residues within 4Å:- Chain K: N.103, I.108, D.110, D.111, M.112, R.113
2 PLIP interactions:2 interactions with chain K- Hydrophobic interactions: K:R.113
- Hydrogen bonds: K:D.110
NAG-NAG.22: 2 residues within 4Å:- Chain K: N.271, I.292
No protein-ligand interaction detected (PLIP)NAG-NAG.24: 2 residues within 4Å:- Chain K: N.416
- Ligands: NAG-NAG-BMA-MAN-MAN.25
No protein-ligand interaction detected (PLIP)NAG-NAG.33: 6 residues within 4Å:- Chain Q: N.103, I.108, D.110, D.111, M.112, R.113
2 PLIP interactions:2 interactions with chain Q- Hydrophobic interactions: Q:R.113
- Hydrogen bonds: Q:D.110
NAG-NAG.36: 2 residues within 4Å:- Chain Q: N.271, I.292
No protein-ligand interaction detected (PLIP)NAG-NAG.38: 2 residues within 4Å:- Chain Q: N.416
- Ligands: NAG-NAG-BMA-MAN-MAN.39
No protein-ligand interaction detected (PLIP)- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.43: 1 residues within 4Å:- Chain C: N.308
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.308
NAG.44: 3 residues within 4Å:- Chain C: N.361
- Ligands: NAG-NAG-BMA.3, NAG-NAG-BMA-MAN-MAN.4
No protein-ligand interaction detected (PLIP)NAG.45: 3 residues within 4Å:- Chain C: R.162, N.167
- Chain K: R.278
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain K- Hydrogen bonds: C:R.162, C:N.167, K:R.278, K:R.278
NAG.46: 1 residues within 4Å:- Chain K: N.308
1 PLIP interactions:1 interactions with chain K- Hydrogen bonds: K:N.308
NAG.47: 3 residues within 4Å:- Chain K: N.361
- Ligands: NAG-NAG-BMA.17, NAG-NAG-BMA-MAN-MAN.18
No protein-ligand interaction detected (PLIP)NAG.48: 3 residues within 4Å:- Chain K: R.162, N.167
- Chain Q: R.278
4 PLIP interactions:2 interactions with chain Q, 2 interactions with chain K- Hydrogen bonds: Q:R.278, Q:R.278, K:R.162, K:N.167
NAG.49: 1 residues within 4Å:- Chain Q: N.308
1 PLIP interactions:1 interactions with chain Q- Hydrogen bonds: Q:N.308
NAG.50: 3 residues within 4Å:- Chain Q: N.361
- Ligands: NAG-NAG-BMA.31, NAG-NAG-BMA-MAN-MAN.32
No protein-ligand interaction detected (PLIP)NAG.51: 3 residues within 4Å:- Chain C: R.278
- Chain Q: R.162, N.167
4 PLIP interactions:2 interactions with chain Q, 2 interactions with chain C- Hydrogen bonds: Q:R.162, Q:N.167, C:R.278, C:R.278
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kong, R. et al., Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization. Cell (2019)
- Release Date
- 2019-07-24
- Peptides
- A12V163-a.01 Heavy chain: AIS
A12V163-a.01 Light chain: BJT
Envelope glycoprotein gp120: CKQ
Envelope glycoprotein gp41: DLR
PGT122 Heavy chain: EMU
PGT122 Light chain: FNV
VRC03 Heavy chain: GOW
VRC03 Light chain: HPX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
3I
1S
HB
4J
2T
LC
BK
AQ
CD
FL
ER
DE
YM
XU
MF
aN
ZV
NG
gO
fW
QH
iP
hX
R
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-3-3-mer
- Ligands
- 21 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kong, R. et al., Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization. Cell (2019)
- Release Date
- 2019-07-24
- Peptides
- A12V163-a.01 Heavy chain: AIS
A12V163-a.01 Light chain: BJT
Envelope glycoprotein gp120: CKQ
Envelope glycoprotein gp41: DLR
PGT122 Heavy chain: EMU
PGT122 Light chain: FNV
VRC03 Heavy chain: GOW
VRC03 Light chain: HPX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
3I
1S
HB
4J
2T
LC
BK
AQ
CD
FL
ER
DE
YM
XU
MF
aN
ZV
NG
gO
fW
QH
iP
hX
R